retatrutide approved The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight-loss results, Trial of next-gen weight-loss drug

However, more recent follow-up studies have failed to show an association between colon cancer and anthranoid laxative use or between colon cancer and the finding of melanosis coli

NO generated by eNOS regulates vascular tone by inhibiting smooth muscle contraction and platelet aggregation

Every batch of Koi CJC-1295 + Ipamorelin is synthesized and lyophilized in the United States, then released against independent third-party laboratory (Freedom Diagnostics Testing) testing

The ClinicalTrials.gov registration A study titled "Effectiveness of Microdosed GLP-1 in Improving Health" (NCT07092605) is registered on ClinicalTrials.gov, suggesting that formal clinical investigation into microdosed GLP-1 approaches is underway

Addiction or even alcohol abuse is a chronic disease that progresses and, if untreated, can end in death

10.1146/annurev-med-043021-014919 35 JayaramH.KolkoM.FriedmanD